Neutral high-generation phosphorus dendrimers inhibit macrophage-mediated inflammatory response in vitro and in vivo
Published 2017 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Neutral high-generation phosphorus dendrimers inhibit macrophage-mediated inflammatory response in vitro and in vivo
Authors
Keywords
-
Journal
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Volume 114, Issue 37, Pages E7660-E7669
Publisher
Proceedings of the National Academy of Sciences
Online
2017-08-29
DOI
10.1073/pnas.1704858114
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- The improvement of M1 polarization in macrophages by glycopeptide derived from Ganoderma lucidum
- (2017) Li-Xin Sun et al. IMMUNOLOGIC RESEARCH
- Bifunctional Phosphorus Dendrimers and Their Properties
- (2016) Anne-Marie Caminade et al. MOLECULES
- Nanoparticles for brain-specific drug and genetic material delivery, imaging and diagnosis
- (2016) Inmaculada Posadas et al. Nanomedicine
- Pharmacological effects of mitraphylline from Uncaria tomentosa in primary human monocytes: Skew toward M2 macrophages
- (2015) S. Montserrat-de la Paz et al. JOURNAL OF ETHNOPHARMACOLOGY
- Metabolic Reprograming of Mononuclear Phagocytes in Progressive Multiple Sclerosis
- (2015) Gillian Margaret Tannahill et al. Frontiers in Immunology
- Macrophage subsets and microglia in multiple sclerosis
- (2014) Jeroen F. J. Bogie et al. ACTA NEUROPATHOLOGICA
- Macrophages: A double-edged sword in experimental autoimmune encephalomyelitis
- (2014) Zhilong Jiang et al. IMMUNOLOGY LETTERS
- Modulation of pro-inflammatory activation of monocytes and dendritic cells by aza-bis-phosphonate dendrimer as an experimental therapeutic agent
- (2014) Yannick Degboé et al. ARTHRITIS RESEARCH & THERAPY
- Expand classical drug administration ways by emerging routes using dendrimer drug delivery systems: A concise overview
- (2013) Serge Mignani et al. ADVANCED DRUG DELIVERY REVIEWS
- Macrophages in inflammatory multiple sclerosis lesions have an intermediate activation status
- (2013) Daphne YS Vogel et al. Journal of Neuroinflammation
- M2 microglia and macrophages drive oligodendrocyte differentiation during CNS remyelination
- (2013) Veronique E Miron et al. NATURE NEUROSCIENCE
- Mannodendrimers prevent acute lung inflammation by inhibiting neutrophil recruitment
- (2013) E. Blattes et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Proteinase-activated receptor 2 activation promotes an anti-inflammatory and alternatively activated phenotype in LPS-stimulated murine macrophages
- (2011) Quan M Nhu et al. Innate Immunity
- Dendrimer-mediated siRNA delivery knocks down Beclin 1 and potentiates NMDA-mediated toxicity in rat cortical neurons
- (2011) María D. Pérez-Carrión et al. JOURNAL OF NEUROCHEMISTRY
- Inhibition of p42 MAPK using a nonviral vector-delivered siRNA potentiates the anti-tumor effect of metformin in prostate cancer cells
- (2011) Silvia Monteagudo et al. Nanomedicine
- A Phosphorus-Based Dendrimer Targets Inflammation and Osteoclastogenesis in Experimental Arthritis
- (2011) M. Hayder et al. Science Translational Medicine
- Guidelines for reporting experiments involving animals: the ARRIVE guidelines
- (2010) JC McGrath et al. BRITISH JOURNAL OF PHARMACOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation